User menu

Inhibition of caspase activity does not prevent the signaling phase of apoptosis in prostate cancer cells.

Bibliographic reference Denmeade, S R ; Lin, X S ; Tombal, Bertrand ; Isaacs, J T. Inhibition of caspase activity does not prevent the signaling phase of apoptosis in prostate cancer cells.. In: The Prostate, Vol. 39, no. 4, p. 269-79 (1999)
Permanent URL http://hdl.handle.net/2078.1/22605
  1. Thompson, Science, 267, 1456 (1995)
  2. Isaacs, Environ Health Perspect, 101, 27 (1993)
  3. Kerr J F R, Wyllie A H, Currie A R, Apoptosis: A Basic Biological Phenomenon with Wideranging Implications in Tissue Kinetics, 10.1038/bjc.1972.33
  4. Eastman, Semin Cancer Biol, 6, 45 (1995)
  5. Zhivotovsky, Exp Cell Res, 221, 404 (1995)
  6. Evan, Science, 281, 1317 (1998)
  7. Ashekenazi, Science, 281, 1305 (1998)
  8. Green, Science, 281, 1309 (1998)
  9. Thornberry, Science, 281, 1312 (1998)
  10. Yagoda, Cancer, 71, 1098 (1993)
  11. Carter, Semin Urol, 6, 262 (1988)
  12. Berges, Clin Cancer Res, 1, 473 (1995)
  13. Thastrup, Proc Natl Acad Sci USA, 87, 2466 (1990)
  14. Furuya, Cancer Res, 54, 6167 (1994)
  15. Lin, Prostate, 33, 201 (1997)
  16. Furuya, Prostate, 25, 301 (1994)
  17. Tombal, Cell Calcium, 25, 19 (1999)
  18. Apoptotic pathways in prostate cancer. In: editor. Programmed cell death: role in disease, pathogenesis, and prevention. Greenwich: JAI Press, Inc., 1999.
  19. Qi, Oncogene, 15, 1207 (1997)
  20. Browne, Cell Death Differ, 5, 206 (1998)
  21. COHEN Gerald M., Caspases: the executioners of apoptosis, 10.1042/bj3260001
  22. Thornberry N. A, The caspase family of cysteine proteases, 10.1093/oxfordjournals.bmb.a011625
  23. Villa, TIBS, 22, 00 (1997)
  24. Marcelli, Cancer Res, 58, 76 (1998)
  25. Marcelli, Cancer Res, 59, 382 (1999)
  26. Bowen, Cancer Res, 58, 3275 (1998)
  27. Zhao, J Biol Chem, 272, 22751 (1997)
  28. Srikanth, Cancer Res, 58, 834 (1998)
  29. Deveraux, EMBO J, 17, 2215 (1998)
  30. Cardone, Science, 282, 1318 (1998)
  31. Miura, Proc Natl Acad Sci USA, 92, 8318 (1995)
  32. Martikainen, Cancer Res, 51, 4693 (1991)
  33. Iizumi, J Urol, 137, 1304 (1987)
  34. Furuya, Endocrinology, 136, 1898 (1995)
  35. Gerlach, Lab Invest, 77, 697 (1997)
  36. Furuya, Clin Cancer Res, 2, 389 (1996)
  37. Knudsen E S, Wang J Y, Dual mechanisms for the inhibition of E2F binding to RB by cyclin-dependent kinase-mediated RB phosphorylation., 10.1128/mcb.17.10.5771
  38. Chen, Oncogene, 14, 1243 (1997)
  39. Janicke, EMBO J, 15, 6969 (1996)
  40. An, Cancer Res, 56, 438 (1996)
  41. Fan, Oncogene, 12, 1909 (1996)
  42. Thornberry, J Biol Chem, 272, 17907 (1997)
  43. Lazebnik, Nature, 371, 346 (1994)
  44. Kaufmann, Cancer Res, 53, 3976 (1993)
  45. Song, EMBO J, 15, 3238 (1996)
  46. Kothakota, Science, 278, 294 (1997)
  47. Li, Cell, 91, 479 (1996)
  48. Hakem, Cell, 94, 339 (1998)
  49. Kuida, Cell, 94, 325 (1998)
  50. Susin, J Exp Med, 186, 25 (1997)
  51. McConkey, J Biol Chem, 271, 22398 (1996)
  52. Alain-Théophile, Cancer Res, 58, 3066 (1998)
  53. Lazebnik, Proc Natl Acad Sci USA, 92, 9042 (1995)
  54. Takahashi, J Biol Chem, 271, 32487 (1996)
  55. Denmeade, Cancer J Sci Am, 4, 15 (1998)
  56. Thapsigargin analogues for targeting programmed death of androgen-independent prostatic cancer cells. Bioorg Med Chem 1998; in press.
  57. Denmeade, Cancer Res, 57, 4924 (1997)
  58. Denmeade, Cancer Res, 58, 2537 (1998)